Aura Biosciences, Inc.

NasdaqGM:AURA Stock Report

Market Cap: US$447.1m

Aura Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:AURA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 Nov 24SellUS$110,663Jill HopkinsIndividual11,822US$9.36
29 Oct 24SellUS$5,938Amy ElazzouziIndividual553US$10.74
29 Oct 24SellUS$98,788Elisabet de los PinosIndividual9,200US$10.74
16 Oct 24SellUS$72,723Mark PlavsicIndividual7,383US$9.85
23 Jan 24SellUS$50,521Julie FederIndividual6,609US$7.64
23 Jan 24SellUS$121,141Elisabet de los PinosIndividual15,853US$7.64

Insider Trading Volume

Insider Buying: AURA insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of AURA?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders793,6281.59%
VC/PE Firms3,039,8926.09%
General Public8,052,07216.1%
Hedge Funds11,803,99523.6%
Institutions26,261,87952.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 78.99% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13.9%
Matrix Capital Management Company, LP
6,922,870US$62.0m0%2.53%
11.6%
Eventide Asset Management, LLC
5,802,682US$51.9m0%0.89%
9.77%
Adage Capital Management, L.P.
4,881,125US$43.7m-0.08%0.07%
6.33%
BlackRock, Inc.
3,160,414US$28.3m5.16%no data
6.09%
Medicxi Ventures (UK) LLP
3,039,892US$27.2m0%5.41%
4.05%
Advent Life Sciences LLP
2,023,857US$18.1m0%100.0%
4.04%
Lundbeckfonden BioCapital
2,017,652US$18.1m0%0.28%
3.61%
The Vanguard Group, Inc.
1,805,434US$16.2m2.15%no data
3.34%
Franklin Resources, Inc.
1,668,960US$14.9m14.8%0.01%
2.54%
Nantahala Capital Management, LLC
1,270,035US$11.4m0%0.9%
2.27%
Long Focus Capital Management LLC
1,133,546US$10.1m7.22%0.88%
2.02%
Geode Capital Management, LLC
1,008,827US$9.0m4.06%no data
1.51%
State Street Global Advisors, Inc.
754,803US$6.8m3.69%no data
1.34%
Regency Capital Management Inc.
667,311US$6.0m-12.8%3.2%
1.03%
T. Rowe Price Group, Inc.
516,126US$4.6m-10%no data
1.03%
Decheng Capital LLC
515,555US$4.6m0%0.99%
0.83%
Levin Capital Strategies, L.P.
413,635US$3.7m26.3%0.35%
0.73%
Northern Trust Global Investments
364,263US$3.3m24.6%no data
0.59%
Dimensional Fund Advisors LP
292,762US$2.6m16.9%no data
0.57%
David Johnson
285,667US$2.6m0%no data
0.55%
Ensign Peak Advisors, Inc.
272,695US$2.4m8.25%no data
0.36%
Elisabet de los Pinos
179,129US$1.6m5.53%no data
0.33%
Platinum Investment Management Limited
162,358US$1.5m0%0.05%
0.3%
Jill Hopkins
151,693US$1.4m0%no data
0.29%
Morgan Stanley, Investment Banking and Brokerage Investments
145,708US$1.3m160%no data